Stay updated with breaking news from Lobe Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding...
Providing a Proven Track Record of Driving Growth and Innovation ...
Lobe Sciences (TSE:LOBE) has released an update. Lobe Sciences Ltd., a biopharmaceutical company, has announced a change of control after Clearway ...
Lobe Sciences Ltd. , a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC , a wholly owned subsidiary of Sancilio & Company , a...
12-month data confirming that L-130 is the first reported stable oral psilocin First-in-Man clinical data demonstrates the superior PK profile of L-130 2023 sales of $1.1M for Altemia® ...